VanEck Pharmaceutical ETF (PPH) Stock Price, Quote, News & History

PPHNASDAQ
$110.53
-0.61-0.55%
At close: Sep 15, 5:00 PM EST
$110.50
-0.0338-0.03%
After Hours: 5:20 PM EST

VanEck Pharmaceutical ETF (PPH) Stock Price, Quote, News & History | Benzinga

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Sector
Healthcare
Region
US
AUM
984.92M
Fund Score
Loading...

Key Statistics

Open
$110.96
High
$111.04
52 Wk High
$118.00
AUM
984.92M
Dividend
$2.17
Ex-Div Date
Jul 1, 2026
Volume
97.95K
Market Cap
$383.66B
Mgmt Fee
0.35%
P/E Ratio
28.29
Prev. Close
$111.14
Low
$110.01
52 Wk Low
$85.91
Shares Out
6.09M
Yield
1.95%
Div. Freq
-
Avg. Volume Daily
258.21K
Beta
0.46
Avg. Expense Ratio
0.36%
P/B Ratio
5.69

Recent VanEck Pharmaceutical ETF News

FAQ

Q

How do I buy VanEck Pharmaceutical ETF (PPH) stock?

A

You can purchase shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are VanEck Pharmaceutical ETF (PPH) competitors?

A

There are no as such competitors for VanEck Pharmaceutical ETF.

Q

What is the forecast, or price target, for VanEck Pharmaceutical ETF (PPH) stock?

A

There is no analysis for VanEck Pharmaceutical ETF to provide a consensus price target.

Q

What is the current price for VanEck Pharmaceutical ETF (PPH)?

A

The stock price for VanEck Pharmaceutical ETF (NASDAQ: PPH) is $110.5 last updated September 15, 2026 at 5:20 PM EDT.

Q

Does VanEck Pharmaceutical ETF (PPH) pay a dividend?

A

There are no upcoming dividends for VanEck Pharmaceutical ETF.

Q

When is VanEck Pharmaceutical ETF (NASDAQ:PPH) reporting earnings?

A

VanEck Pharmaceutical ETF does not have any upcoming earnings scheduled.

Q

Is VanEck Pharmaceutical ETF (PPH) going to split?

A

There is no upcoming split for VanEck Pharmaceutical ETF.

Key Statistics

Open
$110.96
High
$111.04
52 Wk High
$118.00
AUM
984.92M
Dividend
$2.17
Ex-Div Date
Jul 1, 2026
Volume
97.95K
Market Cap
$383.66B
Mgmt Fee
0.35%
P/E Ratio
28.29
Prev. Close
$111.14
Low
$110.01
52 Wk Low
$85.91
Shares Out
6.09M
Yield
1.95%
Div. Freq
-
Avg. Volume Daily
258.21K
Beta
0.46
Avg. Expense Ratio
0.36%
P/B Ratio
5.69

About

Sector
N/A
Industry
N/A
ETF Details
SectorHealthcare
CategoryMid Performer-Mid Growth
Investment StyleLarge Cap Value
Fund InceptionDec 20, 2011
Managers
Griffin Driscoll
Peter H. Liao
DefinitionMost of the stocks in this equity fund have average financial performance and average growth potential
Investment Policy
The Fund normally invests at least 80 percent of its total assets in securities that comprise the Funds benchmark index. The Pharmaceutical Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. To be initially eligible for the Pharmaceutical Index, companies must generate at least 50 percent of their revenues from pharmaceuticals. Pharmaceuticals include companies engaged primarily in research (including research contractors) and development as well as production, marketing and sales of pharmaceuticals (excluding pharmacies). Of the largest 50 stocks in the pharmaceutical industry by full market capitalization, the top 25 by free-float market capitalization (i.e., includes only shares that are readily available for trading in the market) and three month average daily trading volume are included in the Pharmaceutical Index.
Top ETF Holdings
SymbolNameShare %
LLYEli Lilly & Co.19.6%
CONovo Nordisk A/S ADR4.96%
MRKMerck & Co. Inc.9.79%
LNGSK plc4.32%
SMNovartis Ag Sponsored ...10.4%
PFEPfizer, Inc.4.81%
BMYBristol-Myers Squibb C...4.91%
JNJJohnson & Johnson - Co...4.40%
ABBVAbbvie Inc.4.46%
MCKMckessoncorp.4.77%